A CRISPR kidney that is part pig, part person is just another step toward editing our children’s genes. Call it sci-fi ...

Researchers at the Salk Institute have used CRISPR to uncover hidden microproteins that control fat cell growth and lipid ...

The obesity rate has more than doubled in the last 30 years, affecting more than one billion people worldwide.

Salk Institute scientists are looking for a new treatment strategy in microproteins, an understudied class of molecules found ...

The FDA's approval of the first CRISPR-Cas9–based gene therapy marked a major milestone in biomedicine, validating genome ...

Zacks.com users have recently been watching CRISPR Therapeutics (CRSP) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Researchers developed a method to dissect immune-regulatory programs via integrative time-series analysis and high-content CRISPR screening.

Mars, maker of M&M's and Skittles, is turning to CRISPR gene editing to develop more resilient cacao plants, with the aim of ...

Detailed price information for Crispr Therapeutics Ag (CRSP-Q) from The Globe and Mail including charting and trades.

CRISPR Therapeutics, trading under, operates within the biotechnology sector, a key area of interest within the broader ...

Crispr Therapeutics AG has experienced a notable stock price decline of 7.70% over the past week, despite recent positive developments. The downturn comes amid a backdrop of signi ...